Difference between revisions of "Negative for intraepithelial lesion or malignancy"
Jump to navigation
Jump to search
(more) |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''Negative for intraepithelial lesion or malignancy''', abbreviated '''NILM''',<ref>{{Cite journal | last1 = Sturgis | first1 = CD. | last2 = Schaaf | first2 = MR. | last3 = Tickman | first3 = RJ. | title = Focused rescreening of NILM Pap slides from women ≥ 30 years of age with positive high risk HPV DNA: an enhanced quality control measure. | journal = Diagn Cytopathol | volume = 41 | issue = 5 | pages = 399-403 | month = May | year = 2013 | doi = 10.1002/dc.22829 | PMID = 22351303 }} | '''Negative for intraepithelial lesion or malignancy''', abbreviated '''NILM''',<ref>{{Cite journal | last1 = Sturgis | first1 = CD. | last2 = Schaaf | first2 = MR. | last3 = Tickman | first3 = RJ. | title = Focused rescreening of NILM Pap slides from women ≥ 30 years of age with positive high risk HPV DNA: an enhanced quality control measure. | journal = Diagn Cytopathol | volume = 41 | issue = 5 | pages = 399-403 | month = May | year = 2013 | doi = 10.1002/dc.22829 | PMID = 22351303 }} | ||
</ref> is the common terminology for - both of the following: | </ref> is the common terminology for - both of the following: | ||
*No [[SIL]] is present. | *No [[Squamous intraepithelial lesion|squamous intraepithelial lesion (SIL)]] is present. | ||
*No malignancy is present. | *No malignancy is present. | ||
NILM does not exclude the presence of other findings, e.g. [[candida]].<ref>{{Cite journal | last1 = Moriarty | first1 = AT. | last2 = Darragh | first2 = TM. | last3 = Fatheree | first3 = LA. | last4 = Souers | first4 = R. | last5 = Wilbur | first5 = DC. | title = Performance of Candida--fungal-induced atypia and proficiency testing: observations from the College of American Pathologists proficiency testing program. | journal = Arch Pathol Lab Med | volume = 133 | issue = 8 | pages = 1272-5 | month = Aug | year = 2009 | doi = 10.1043/1543-2165-133.8.1272 | PMID = 19653724 }}</ref> | NILM does not exclude the presence of other findings, e.g. [[candida]].<ref>{{Cite journal | last1 = Moriarty | first1 = AT. | last2 = Darragh | first2 = TM. | last3 = Fatheree | first3 = LA. | last4 = Souers | first4 = R. | last5 = Wilbur | first5 = DC. | title = Performance of Candida--fungal-induced atypia and proficiency testing: observations from the College of American Pathologists proficiency testing program. | journal = Arch Pathol Lab Med | volume = 133 | issue = 8 | pages = 1272-5 | month = Aug | year = 2009 | doi = 10.1043/1543-2165-133.8.1272 | PMID = 19653724 }}</ref> | ||
==Sign out== | |||
<pre> | |||
Negative for intraepithelial lesion or malignancy (NILM). | |||
</pre> | |||
==See also== | ==See also== | ||
*[[Gynecologic cytopathology]]. | *[[Gynecologic cytopathology]]. | ||
*[[Uterine cervix]]. | |||
==References== | ==References== | ||
Latest revision as of 20:26, 22 September 2015
Negative for intraepithelial lesion or malignancy, abbreviated NILM,[1] is the common terminology for - both of the following:
- No squamous intraepithelial lesion (SIL) is present.
- No malignancy is present.
NILM does not exclude the presence of other findings, e.g. candida.[2]
Sign out
Negative for intraepithelial lesion or malignancy (NILM).
See also
References
- ↑ Sturgis, CD.; Schaaf, MR.; Tickman, RJ. (May 2013). "Focused rescreening of NILM Pap slides from women ≥ 30 years of age with positive high risk HPV DNA: an enhanced quality control measure.". Diagn Cytopathol 41 (5): 399-403. doi:10.1002/dc.22829. PMID 22351303.
- ↑ Moriarty, AT.; Darragh, TM.; Fatheree, LA.; Souers, R.; Wilbur, DC. (Aug 2009). "Performance of Candida--fungal-induced atypia and proficiency testing: observations from the College of American Pathologists proficiency testing program.". Arch Pathol Lab Med 133 (8): 1272-5. doi:10.1043/1543-2165-133.8.1272. PMID 19653724.